EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Milan system atypia of undetermined significance: 5‐year performance data

Henri Lagerstam, Erkka Tommola, Saara Kares, Ivana Kholová iD

Cancer Cytopathology · 2024

DOI: 10.1002/cncy.22883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, 2024. Verfasst von Henri Lagerstam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Emil Aaltosen Säätiö, VTR Government Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this study was to evaluate the diagnostic performance of the category atypia of undetermined significance (AUS) at the authors' institution based on the Milan System for Reporting Salivary Gland Cytopathology.

Methods

All AUS cases diagnosed at Fimlab Laboratories between January 1, 2018, and December 31, 2022, were included. Histologic verifications were checked until May 31, 2023. The upper‐bound and lower‐bound risk of malignancy and risk of neoplasm were calculated. The timelines between the pathology laboratory workflow and patient management were also calculated.

Results

From 1157 fine‐needle aspirations (FNAs), 162 (14.0%) AUS cases were diagnosed in 146 patients, with an average ± standard deviation age of 66.1 ± 14.9 years. There was variation in the AUS percentages, with higher values during the coronavirus disease 2019 pandemic years (15% and 17.5% in 2020 and 2021, respectively). Seventy‐five cases (46.3%) had histologic follow‐up: 16 were malignant neoplasms, and 36 were benign neoplasms. The upper and the lower bounds of the‐risk of malignancy and risk of neoplasm were 21.3% and 69.3% and 9.9% and 32.1%, respectively. The average time from the first FNA with an AUS diagnosis to surgical resection ranged from 6 to 682 days, and the time to the first repeat FNA ranged from 10 to 691 days.

Conclusions

The results indicated higher percentages of AUS cases compared with the reference value, which may be attributed to the impact of the coronavirus disease 2019 pandemic. The risk of malignancy calculated in this study was closer to the reference value from the first edition of the Milan System for Reporting Salivary Gland Cytopathology compared with the second edition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary Gland NeoplasmsHumansAgedFemaleMaleBiopsy, Fine-NeedleMiddle AgedAged, 80 and overCOVID-19Salivary GlandsAdultRetrospective StudiesCytodiagnosisSARS-CoV-2

Stichwörter der Autor:innen

The Milan System for Reporting Salivary Gland Cytopathologycoronavirus disease 2019 (COVID‐19) pandemicfine‐needle aspirationlaboratory workflowpatient management, salivary gland

Autor:innen und Institutionen

  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Pathology, Fimlab Laboratories, Tampere, Finland.

ORCID-Profile: Ivana Kholová

Förderung

  • Emil Aaltosen Säätiö
  • VTR Government Research

Zitieren

APA

Lagerstam, H., Tommola, E., Kares, S., & Kholová, I. (2024). The Milan system atypia of undetermined significance: 5‐year performance data. Cancer Cytopathology. https://doi.org/10.1002/cncy.22883

Vancouver

Lagerstam H, Tommola E, Kares S, Kholová I. The Milan system atypia of undetermined significance: 5‐year performance data. Cancer Cytopathology. 2024. doi:10.1002/cncy.22883

BibTeX
@article{Lagerstam2024,
  author = {Lagerstam, Henri and Tommola, Erkka and Kares, Saara and Kholová, Ivana},
  title = {The Milan system atypia of undetermined significance: 5‐year performance data},
  journal = {Cancer Cytopathology},
  year = {2024},
  doi = {10.1002/cncy.22883}
}
Kostenlos starten →